CMBA
BRLI

C.M. Bidwell & Associates’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

C.M. Bidwell & Associates’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,970
Closed -$210K – 282
2015
Q1 		$210K Hold
5,970
– – 0.05% 151
2014
Q4 		$192K Buy
+5,970
New +$173K 0.04% 152

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

C.M. Bidwell & Associates's BRLI Position: Q2 2015 in Review

C.M. Bidwell & Associates sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 5,970 shares — an estimated $210K sold.

C.M. Bidwell & Associates first reported a position in BRLI in Q4 2014 and held it in 2 quarters. The position peaked at $210K in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • C.M. Bidwell & Associates reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 5,970 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $210K.
  • C.M. Bidwell & Associates first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 2 quarters.
  • C.M. Bidwell & Associates's BIO-REFERENCE LABS INC-NEW- position peaked at $210K in Q1 2015.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2015, filed 21 Aug 2015.